Cardiol Therapeutics Inc.
CRDL
$1.01
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.40% | -93.75% | 29.26% | -21.29% | -26.97% |
| Total Depreciation and Amortization | -12.63% | -12.39% | -1.09% | -6.92% | 1.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.12% | 682.80% | -57.02% | 618.95% | -116.22% |
| Change in Net Operating Assets | 136.10% | -442.92% | 2,584.78% | -102.03% | 936.39% |
| Cash from Operations | 29.85% | -63.21% | 32.03% | -8.06% | -86.66% |
| Capital Expenditure | 24.14% | -107.14% | -7.69% | 67.09% | -88.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 24.14% | -107.14% | -7.69% | 67.09% | -88.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00% | 50.00% | 33.33% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | -3.22% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 392,805.88% | -105.95% | 0.88% | 654.90% | 0.97% |
| Foreign Exchange rate Adjustments | 540.69% | -337.66% | -69.97% | -43.74% | 189.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 275.98% | -79.33% | 29.47% | -14.41% | -25.60% |